NMDA受体
缺氧(环境)
兴奋毒性
神经毒性
药理学
医学
毒性
受体
神经科学
生物
内科学
化学
有机化学
氧气
作者
Chong-Yin Huang,Meng‐Ting Zuo,Xue‐Jia Qi,Meng‐Die Gong,Wenbo Xu,Si-Yu Meng,J.P. Long,Pishun Li,Zhi‐Liang Sun,Xiao-Feng Zheng,Zhao‐Ying Liu
出处
期刊:BMC Medicine
[BioMed Central]
日期:2025-03-12
卷期号:23 (1)
被引量:1
标识
DOI:10.1186/s12916-025-03984-5
摘要
Abstract Background Gelsemium elegans ( G. elegans ) is widely recognized as one of the most toxic plants globally, particularly harmful to humans. Some reports indicate that it is non-toxic to pigs and even has a growth-promoting effect; however, the underlying reasons for this paradox remain unclear. Methods Gelsenicine is the main toxic component of G. elegans . This study characterized gelsenicine-induced toxicity using electrophysiological recordings, molecular dynamic simulations, c-Fos immunostaining, and multi-omics technologies. Additionally, we conducted a comprehensive analysis comparing the toxic effects of gelsenicine across various animal species through examinations of tissue distribution, blood gas analysis, metabonomics, and behavioral tests. Results We demonstrated that gelsenicine-induced hypoxia leads to respiratory depression in mice by enhancing the effect of gamma-aminobutyric acid (GABA) on GABA receptors (GABARs). Glycine significantly ameliorated hypoxia and improved the survival of gelsenicine-poisoned mice. Under gelsenicine-induced hypoxic conditions, N-methyl-D-aspartate (NMDA) receptor function and mitochondrial energy metabolism processes were perturbed, resulting in neuronal excitotoxicity. Finally, we confirmed that pigs could tolerate hypoxia and were resistant to gelsenicine toxicity due to high concentrations of circulating glycine and low levels of NMDA receptors (NMDARs) in the hippocampus. Conclusions These findings suggest that hypoxic protection should be considered as a potential therapeutic strategy for gelsenicine poisoning. Our study contributes to preventing potential risks posed by G. elegans poisoning to human and animal health. Graphical Abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI